Study of MicroRNA (miR-221-3p, miR-133a-3p, and miR-9-5p) Expressions in Oral Submucous Fibrosis and Squamous Cell Carcinoma
- PMID: 36684498
- PMCID: PMC9852399
- DOI: 10.1007/s12291-022-01035-x
Study of MicroRNA (miR-221-3p, miR-133a-3p, and miR-9-5p) Expressions in Oral Submucous Fibrosis and Squamous Cell Carcinoma
Abstract
Oral squamous cell carcinoma (OSCC) is one of the common types of cancer. Its progression follows a transition from oral potentially malignant disorders (OPMDs) such as oral submucous fibrosis (OSMF). Epigenetic modifiers, especially microRNAs (miRNAs), have an appreciable role in the regulation of various carcinogenic pathways which are being used as biomarkers. miRNAs may also be helpful in the differentiation of oral submucous fibrosis from oral squamous cell carcinoma. Three miRNAs, miR-221-3p, miR133a-3p, and miR-9-5p, were found differentially expressed in many cancers in the literature search supported by our preliminary database search-based screening. The literature and our functional enrichment analysis in an earlier study have reported these miRNAs to regulate carcinogenesis at various steps. In the present study, the expression of these miRNAs was examined in 34 histopathologically confirmed OSCC, 30 OSMF, and 29 control (healthy volunteers) human samples. There was a significant downregulation of miRNA-133a-3p in OSCC compared to OSMF and controls, whereas there was up-regulation in oral submucous fibrosis compared to controls. There was no significant difference in the expression of miR-221-3p between OSCC and OSMF, but an upregulation in OSCC compared to controls. miR-9-5p was also found upregulated in both OSCC and OSMF. Further, miR-133a-3p expression was negatively correlated with age, smoking, drinking status, and AJCC staging, whereas miR-9-5p expression was only positively associated with tobacco/ areca nut chewing. The ROC plots, logistic regression model generated, and the correlation between the expression of miR-9-5p and miR-133a-3p in blood and tissue suggests that these could be used as risk stratification biomarkers.
Keywords: Interactomics; Oral squamous cell carcinoma; Oral submucous fibrosis; Risk stratification biomarkers; microRNAs.
© The Author(s), under exclusive licence to Association of Clinical Biochemists of India 2022.
Conflict of interest statement
Conflict of interestThe authors declare that they have no conflict of interest.
Figures
Similar articles
-
Correlation of hsa miR-101-5p and hsa miR-155-3p Expression With c-Fos in Patients of Oral Submucous Fibrosis (OSMF) and Oral Squamous Cell Carcinoma (OSCC).J Maxillofac Oral Surg. 2023 Jun;22(2):381-387. doi: 10.1007/s12663-021-01668-0. Epub 2021 Nov 27. J Maxillofac Oral Surg. 2023. PMID: 37122804 Free PMC article.
-
Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.Asian Pac J Cancer Prev. 2018 Apr 27;19(4):1053-1057. doi: 10.22034/APJCP.2018.19.4.1053. Asian Pac J Cancer Prev. 2018. PMID: 29699056 Free PMC article.
-
Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.J Cancer Res Ther. 2022 Jan-Mar;18(1):55-65. doi: 10.4103/jcrt.JCRT_508_20. J Cancer Res Ther. 2022. PMID: 35381762
-
[Oral squamous cell carcinoma in the background of oral submucous fibrosis - a systematic review].Arkh Patol. 2024;86(1):57-64. doi: 10.17116/patol20248601157. Arkh Patol. 2024. PMID: 38319274 Russian.
-
Review of Disease-Specific microRNAs by Strategically Bridging Genetics and Epigenetics in Oral Squamous Cell Carcinoma.Genes (Basel). 2023 Aug 2;14(8):1578. doi: 10.3390/genes14081578. Genes (Basel). 2023. PMID: 37628629 Free PMC article. Review.
Cited by
-
Noncoding RNAs: Master Regulator of Fibroblast to Myofibroblast Transition in Fibrosis.Int J Mol Sci. 2023 Jan 16;24(2):1801. doi: 10.3390/ijms24021801. Int J Mol Sci. 2023. PMID: 36675315 Free PMC article. Review.
-
The Use of Diagnostic Tumor Markers in Detecting Tobacco- and Betel Quid-Induced Oral Squamous Cell Carcinoma: A Scoping Review of Empirical Evidence.Health Sci Rep. 2025 Apr 18;8(4):e70650. doi: 10.1002/hsr2.70650. eCollection 2025 Apr. Health Sci Rep. 2025. PMID: 40256126 Free PMC article. Review.
-
Clinical and molecular evaluation of patients with ovarian cancer in the context of drug resistance to chemotherapy.Front Oncol. 2022 Aug 5;12:954008. doi: 10.3389/fonc.2022.954008. eCollection 2022. Front Oncol. 2022. PMID: 35992817 Free PMC article.
-
Expression of SOX10, and micro-RNA 221 and Micro-RNA 222 in Oral Squamous Cell Carcinoma and Correlation with Clinicopathological Characteristics.Head Neck Pathol. 2025 Jun 25;19(1):76. doi: 10.1007/s12105-025-01809-8. Head Neck Pathol. 2025. PMID: 40560444
-
Bioinformatics analysis of miRNA and its associated genes to identify potential biomarkers of oral submucous fibrosis and oral malignancy.Cancer Rep (Hoboken). 2023 Apr;6(4):e1787. doi: 10.1002/cnr2.1787. Epub 2023 Jan 28. Cancer Rep (Hoboken). 2023. PMID: 36708238 Free PMC article.
References
-
- Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles M, Kerr AR, et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2020. - PubMed
-
- Dionne KR, Warnakulasuriya S, Zain RB, Cheong SC. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int J Cancer. 2015;136(3):503–15. - PubMed
-
- Shih Y-H, Wang T-H, Shieh T-M, Tseng Y-H. Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy. Int J Mol Sci [Internet]. 2019 Jun 16 [cited 2020 Jul 22];20(12). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627879/. - PMC - PubMed
LinkOut - more resources
Full Text Sources